306 related articles for article (PubMed ID: 33011884)
1. The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment.
Daw S; Law S
Mol Cell Biochem; 2021 Feb; 476(2):535-551. PubMed ID: 33011884
[TBL] [Abstract][Full Text] [Related]
2. Quercetin induces autophagy in myelodysplastic bone marrow including hematopoietic stem/progenitor compartment.
Daw S; Law S
Environ Toxicol; 2021 Feb; 36(2):149-167. PubMed ID: 32902906
[TBL] [Abstract][Full Text] [Related]
3. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
4. Hematopathological alterations of major tumor suppressor cascade, vital cell cycle inhibitors and hematopoietic niche components in experimental myelodysplasia.
Chatterjee R; Gupta S; Law S
Chem Biol Interact; 2017 Aug; 273():1-10. PubMed ID: 28549617
[TBL] [Abstract][Full Text] [Related]
5. FHL2 regulates hematopoietic stem cell functions under stress conditions.
Hou Y; Wang X; Li L; Fan R; Chen J; Zhu T; Li W; Jiang Y; Mittal N; Wu W; Peace D; Qian Z
Leukemia; 2015 Mar; 29(3):615-24. PubMed ID: 25179730
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
7. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic Syndrome related alterations of MAPK signaling in the bone marrow of experimental mice including stem/progenitor compartment.
Daw S; Law A; Law S
Acta Histochem; 2019 Apr; 121(3):330-343. PubMed ID: 30808519
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): why hypercellular marrow strongly favors accelerated apoptosis.
Das M; Chaudhuri S; Law S
Biochem Cell Biol; 2013 Oct; 91(5):303-8. PubMed ID: 24032679
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
11. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
13. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
[TBL] [Abstract][Full Text] [Related]
14. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
16. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Horiguchi H; Kobune M; Kikuchi S; Yoshida M; Murata M; Murase K; Iyama S; Takada K; Sato T; Ono K; Hashimoto A; Tatekoshi A; Kamihara Y; Kawano Y; Miyanishi K; Sawada N; Kato J
Haematologica; 2016 Apr; 101(4):437-47. PubMed ID: 26802051
[TBL] [Abstract][Full Text] [Related]
18. Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity.
Jonas BA; Johnson C; Gratzinger D; Majeti R
PLoS One; 2016; 11(7):e0159189. PubMed ID: 27428079
[TBL] [Abstract][Full Text] [Related]
19. Benzene exposure--an experimental machinery for induction of myelodysplastic syndrome: stem cell and stem cell niche analysis in the bone marrow.
Das M; Chaudhuri S; Law S
J Stem Cells; 2012; 7(1):43-59. PubMed ID: 23550343
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a xenograft model of human myelodysplastic syndromes.
Muguruma Y; Matsushita H; Yahata T; Yumino S; Tanaka Y; Miyachi H; Ogawa Y; Kawada H; Ito M; Ando K
Haematologica; 2011 Apr; 96(4):543-51. PubMed ID: 21193418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
